Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT05377489

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05377489. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 4:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single-arm, Open-label, Phase III Trial to Evaluate the Safety and Tolerability of Intra-articular Injections of RTX-GRT7039 in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

An open-label, single-arm clinical trial to confirm the safety of monoarticular injections or bi-lateral intra-articular injections of RTX-GRT7039 in patients who have pain associated with osteoarthritis of the knee despite standard of care.

Study identification

NCT ID
NCT05377489
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Grünenthal GmbH
Industry
Enrollment
714 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2022 (Actual)
Primary completion
May 15, 2025 (Actual)
Completion
May 15, 2025 (Actual)
Last update posted
Mar 12, 2026

2022 – 2025

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Arizona Arthritis and Rheumatology Associates (AARA) P.C Glendale Arizona 85306 —
Elite Clinical Studies, LLC Phoenix Arizona 85018 —
Orange County Research Institute Anaheim California 92801 —
Acclaim Clinical Research, Inc. San Diego California 92120 —
Westlake Medical Research Thousand Oaks California 91360 —
Progressive Medical Research Port Orange Florida 32127 —
Gulfcoast Research Institute Sarasota Florida 34232 —
Palm Beach Research Center West Palm Beach Florida 33409 —
North Georgia Clinical Research Woodstock Georgia 30189 —
Injury Care Research Boise Idaho 83713 —
Chicago Clinical Research Institute Inc. Chicago Illinois 60607 —
OrthoIndy, Inc. Greenwood Indiana 46143 —
University Of Kansas Medical Center Kansas City Kansas 66160 —
Neuroscience Research Center, LLC Overland Park Kansas 66210 —
Clinical Pharmacology Study Group Worcester Massachusetts 01605 —
Oakland Medical Research Center Troy Michigan 48085 —
Excel Clinical Research Las Vegas Nevada 89109 —
Las Vegas Clinical Trials, LLC North Las Vegas Nevada 89030 —
Drug Trials America Hartsdale New York 10530 —
M3-Emerging Medical Research, LLC Durham North Carolina 27704 —
M3-Emerging Medical Research, LLC Raleigh North Carolina 27704 —
University Orthopedics Center State College Pennsylvania 16801 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
Coastal Carolina Research Center North Charleston South Carolina 29405 —
Accellacare-Knoxville Knoxville Tennessee 37912 —
Tekton Research, Inc. San Antonio Texas 78229 —
Wasatch Clinical Research Salt Lake City Utah 84107 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05377489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2026 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.